Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SRM | Ann: Removal from Official List cob 4/06/2014 | 04/06/14 | 0 | 884 | |||
|
|||||||
RTG +SRM | Ann: Implementation of Schemes of Arrangement | 04/06/14 | 0 | 926 | |||
|
|||||||
SRM | b2 gold owns about 11% of srm | 04/06/14 | 0 | 1.0K | |||
|
|||||||
SRM | thu 5th june | 03/06/14 | 4 | 2.5K | |||
|
|||||||
SRM | Ann: Resignation of a Director | 03/06/14 | 0 | 858 | |||
|
|||||||
SRM | Ann: RTG Mining Inc Completes Share Consolidation | 29/05/14 | 0 | 862 | |||
|
|||||||
SRM | Ann: Appendix 3B | 28/05/14 | 0 | 659 | |||
|
|||||||
SRM | copper at 6 yr lme low. target $3.89lb | 27/05/14 | 0 | 578 | |||
|
See All Discussions